Cargando…

Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies

Celecoxib (CXB) is a COX-2-selective nonsteroidal anti-inflammatory drug used to control pain and various inflammatory conditions. CXB has limited oral bioavailability and a slow dissociation rate due to its poor water solubility. In order to enhance the oral bioavailability of CXB and reduce the fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Rasool, Bazigha K., Khalifa, AlZahraa, Abu-Gharbieh, Eman, Khan, Rawoof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296469/
https://www.ncbi.nlm.nih.gov/pubmed/32596281
http://dx.doi.org/10.1155/2020/1879125
_version_ 1783546848858865664
author Abdul Rasool, Bazigha K.
Khalifa, AlZahraa
Abu-Gharbieh, Eman
Khan, Rawoof
author_facet Abdul Rasool, Bazigha K.
Khalifa, AlZahraa
Abu-Gharbieh, Eman
Khan, Rawoof
author_sort Abdul Rasool, Bazigha K.
collection PubMed
description Celecoxib (CXB) is a COX-2-selective nonsteroidal anti-inflammatory drug used to control pain and various inflammatory conditions. CXB has limited oral bioavailability and a slow dissociation rate due to its poor water solubility. In order to enhance the oral bioavailability of CXB and reduce the frequency of administration, the present study was aimed at enhancing the aqueous solubility of CXB by a cosolvency technique and then at formulating and evaluating a CXB in situ floating gelling system for sustained oral delivery. Three cosolvents, namely, PEG 600, propylene glycol, and glycerin, at different concentrations, were used to solubilize CXB. Particle size analysis was performed to confirm the solubility of CXB in the solutions. The floating in situ gel formulations were then prepared by the incorporation of the CXB solution into sodium alginate solutions (0.25, 0.5, and 1% w/v). Formulations, in sol form, were then in vitro characterized for their physical appearance, pH, and rheological behaviors, while formulations in gel form were evaluated for their floating behavior and in vitro drug release studies. FTIR spectroscopy was performed to examine drug-polymer interaction. The selected formula was evaluated biologically for its anti-inflammatory and analgesic activities. Results revealed that the less-polar solvent PEG 600 at 80% v/v had the highest solubilization potential, and it was used to optimize the in situ gel formulation. The candidate formula (F3) was found to have the highest sodium alginate concentration (1% w/v) and showed the optimum sustained release profile with the Higuchi model release kinetics. The results from the FTIR spectroscopy analysis showed noticeable drug-polymer molecular interaction. Moreover, F3 exhibited a significantly higher percentage of paw edema inhibition at 8 h compared with the reference drug (p < 0.05). Also, it showed a sustained duration of analgesia that persisted for the entire experimental time.
format Online
Article
Text
id pubmed-7296469
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72964692020-06-25 Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies Abdul Rasool, Bazigha K. Khalifa, AlZahraa Abu-Gharbieh, Eman Khan, Rawoof Biomed Res Int Research Article Celecoxib (CXB) is a COX-2-selective nonsteroidal anti-inflammatory drug used to control pain and various inflammatory conditions. CXB has limited oral bioavailability and a slow dissociation rate due to its poor water solubility. In order to enhance the oral bioavailability of CXB and reduce the frequency of administration, the present study was aimed at enhancing the aqueous solubility of CXB by a cosolvency technique and then at formulating and evaluating a CXB in situ floating gelling system for sustained oral delivery. Three cosolvents, namely, PEG 600, propylene glycol, and glycerin, at different concentrations, were used to solubilize CXB. Particle size analysis was performed to confirm the solubility of CXB in the solutions. The floating in situ gel formulations were then prepared by the incorporation of the CXB solution into sodium alginate solutions (0.25, 0.5, and 1% w/v). Formulations, in sol form, were then in vitro characterized for their physical appearance, pH, and rheological behaviors, while formulations in gel form were evaluated for their floating behavior and in vitro drug release studies. FTIR spectroscopy was performed to examine drug-polymer interaction. The selected formula was evaluated biologically for its anti-inflammatory and analgesic activities. Results revealed that the less-polar solvent PEG 600 at 80% v/v had the highest solubilization potential, and it was used to optimize the in situ gel formulation. The candidate formula (F3) was found to have the highest sodium alginate concentration (1% w/v) and showed the optimum sustained release profile with the Higuchi model release kinetics. The results from the FTIR spectroscopy analysis showed noticeable drug-polymer molecular interaction. Moreover, F3 exhibited a significantly higher percentage of paw edema inhibition at 8 h compared with the reference drug (p < 0.05). Also, it showed a sustained duration of analgesia that persisted for the entire experimental time. Hindawi 2020-05-31 /pmc/articles/PMC7296469/ /pubmed/32596281 http://dx.doi.org/10.1155/2020/1879125 Text en Copyright © 2020 Bazigha K. Abdul Rasool et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abdul Rasool, Bazigha K.
Khalifa, AlZahraa
Abu-Gharbieh, Eman
Khan, Rawoof
Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title_full Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title_fullStr Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title_full_unstemmed Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title_short Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies
title_sort employment of alginate floating in situ gel for controlled delivery of celecoxib: solubilization and formulation studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296469/
https://www.ncbi.nlm.nih.gov/pubmed/32596281
http://dx.doi.org/10.1155/2020/1879125
work_keys_str_mv AT abdulrasoolbazighak employmentofalginatefloatinginsitugelforcontrolleddeliveryofcelecoxibsolubilizationandformulationstudies
AT khalifaalzahraa employmentofalginatefloatinginsitugelforcontrolleddeliveryofcelecoxibsolubilizationandformulationstudies
AT abugharbieheman employmentofalginatefloatinginsitugelforcontrolleddeliveryofcelecoxibsolubilizationandformulationstudies
AT khanrawoof employmentofalginatefloatinginsitugelforcontrolleddeliveryofcelecoxibsolubilizationandformulationstudies